Country: United Arab Emirates, Angola, Austria view allAustralia, Belgium, Brazil, Canada, Switzerland, China, Germany, Denmark, Finland, France, Hungary, Indonesia, Israel, India, Italy, Japan, Kenya, South Korea, Liberia, Luxembourg, Moldova, Nigeria, New Zealand, Oman, Philippines, Russian Federation, Sweden, Singapore, Thailand, Turkey, Trinidad and Tobago, United States, Yemen, South Africa, Zimbabwe, United Kingdom
Requirements: Requires iOS 4.0 or later. Compatible with iPhone, iPad, and iPod touch.
Roche ROMAROMA (Risk of Ovarian Malignancy Algorithm) uses CA 125 value, HE4 value, and menopausal status to calculate the risk of a patient’s pelvic mass being malignant ovarian tumor.Among patients presented with pelvic mass, ROMA is more sensitive and specific in identifying ovarian cancer - even stages I/II ovarian cancer - than CA 125 alone.This ROMA calculator App can only be used with...more
Roche ROMA
ROMA (Risk of Ovarian Malignancy Algorithm) uses CA 125 value, HE4 value, and menopausal status to calculate the risk of a patient’s pelvic mass being malignant ovarian tumor.
Among patients presented with pelvic mass, ROMA is more sensitive and specific in identifying ovarian cancer - even stages I/II ovarian cancer - than CA 125 alone. This ROMA calculator App can only be used with results from the Elecsys® CA 125 II and HE4 immunoassays from Roche.
Patient cases in this App were kindly provided by Dr. Rafael Molina, President of ISOBM. Oncology Unit, Laboratory of Clinical Biochemistry, Hospital Clinic, Barcelona, Spain.
